Valuation: CEREP

Market Cap 9.13Cr 10Cr 8.52Cr 7.74Cr 15Cr 988.42Cr 15Cr 102.36Cr 40Cr 502.69Cr 38Cr 38Cr 1.62TCr P/E 2024 *
-
P/E 2025 -
Enterprise Value 7.03Cr 7.86Cr 6.56Cr 5.95Cr 11Cr 760.69Cr 11Cr 79Cr 31Cr 386.87Cr 30Cr 29Cr 1.24TCr EV / Sales 2024
2.02x
EV / Sales 2025 1.67x
Free-Float
4.22%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer - 11/04/2024
Director TitleAgeSince
Chairman - 11/08/2023
Director/Board Member - 23/05/2024
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+4.16%+4.16%+49.37%+94.17% 7.47TCr
+0.46%-0.97%+23.51%+79.57% 5.88TCr
+0.17%+0.35%+6.85%+34.55% 4.84TCr
+0.12%-2.55%+329.50%+685.32% 4.28TCr
-0.60%-3.76%+28.82%+29.67% 4.28TCr
+0.33%-0.36%+6.74%+111.03% 4.12TCr
-0.11%+1.96%+9.19%+52.66% 3.11TCr
-2.07%+1.16%+35.00%+26.28% 3.03TCr
+0.53%-1.75%-8.94%-11.65% 2.4TCr
Average +0.28%-0.25%+53.34%+122.40% 4.38TCr
Weighted average by Cap. +0.68%-0.54%+56.20%+128.71%

Financials

2024 2025
Net sales 4.05Cr 4.53Cr 3.78Cr 3.43Cr 6.46Cr 438.34Cr 6.51Cr 45Cr 18Cr 222.93Cr 17Cr 17Cr 716.65Cr 4.11Cr 4.6Cr 3.83Cr 3.48Cr 6.56Cr 444.96Cr 6.61Cr 46Cr 18Cr 226.29Cr 17Cr 17Cr 727.47Cr
Net income 71.55L 80.07L 66.75L 60.63L 1.14Cr 77Cr 1.15Cr 8.02Cr 3.13Cr 39Cr 3.01Cr 2.94Cr 126.64Cr 47.82L 53.53L 44.62L 40.53L 76.33L 52Cr 76.9L 5.36Cr 2.09Cr 26Cr 2.01Cr 1.97Cr 85Cr
Net Debt -1.73Cr -1.93Cr -1.61Cr -1.46Cr -2.75Cr -186.79Cr -2.77Cr -19Cr -7.56Cr -95Cr -7.25Cr -7.09Cr -305.39Cr -2.1Cr -2.35Cr -1.96Cr -1.78Cr -3.36Cr -227.73Cr -3.38Cr -24Cr -9.21Cr -115.82Cr -8.84Cr -8.65Cr -372.33Cr
Logo CEREP
Eurofins Cerep specializes in the pre-clinical research of drugs for the pharmaceutical industry. Export accounts for 88.2% of net sales.
Employees
-